Naredco-UP signs MoU with UP government to provide jobs to 2.5 lakh labourers

Around 1.25 lakh workers will be absorbed at project sites spread across Ghaziabad, Noida and Greater Noida in Delhi-NCR

Vandana Ramnani

May 29, 2020 / 20:41 IST

To provide employment to labourers who have returned to the state following the coronavirus pandemic, real estate body Naredco’s UP Chapter has signed a Memorandum of Understanding with the UP government to employ 2.5 lakh migrant workers on construction sites spread across the state.

A memorandum of understanding (MoU) was signed by NAREDCO-UP in the presence of Chief Minister Yogi Adityanath on May 29 in Lucknow.

Around 1.25 lakh workers will be absorbed at project sites spread across Ghaziabad, Noida and Greater Noida in NCR, while the remaining 1.25 lakh will be taken for projects across other cities in UP such as Meerut, Kanpur, Bareilly, Moradabad, depending on requirements of developers in these areas.

"Labour shortage is the biggest challenge that the real estate sector faces today. The government is working to resolve this issue on a priority basis. The solution is within our state," RK Arora, Naredco-UP president, told reporters in a video conference.

He said he hopes that through this initiative work on construction sites will resume in full swing within two months.

COVID-19 Vaccine

Frequently Asked Questions

How does a vaccine work?

A vaccine works by mimicking a natural infection. A vaccine not only induces immune response to protect people from any future COVID-19 infection, but also helps quickly build herd immunity to put an end to the pandemic. Herd immunity occurs when a sufficient percentage of a population becomes immune to a disease, making the spread of disease from person to person unlikely. The good news is that SARS-CoV-2 virus has been fairly stable, which increases the viability of a vaccine.

How many types of vaccines are there?

There are broadly four types of vaccine — one, a vaccine based on the whole virus (this could be either inactivated, or an attenuated [weakened] virus vaccine); two, a non-replicating viral vector vaccine that uses a benign virus as vector that carries the antigen of SARS-CoV; three, nucleic-acid vaccines that have genetic material like DNA and RNA of antigens like spike protein given to a person, helping human cells decode genetic material and produce the vaccine; and four, protein subunit vaccine wherein the recombinant proteins of SARS-COV-2 along with an adjuvant (booster) is given as a vaccine.

What does it take to develop a vaccine of this kind?

Vaccine development is a long, complex process. Unlike drugs that are given to people with a diseased, vaccines are given to healthy people and also vulnerable sections such as children, pregnant women and the elderly. So rigorous tests are compulsory. History says that the fastest time it took to develop a vaccine is five years, but it usually takes double or sometimes triple that time.

Show